Losartan, but not Enalapril and Valsartan, Inhibits the Expression of IFN-γ, IL-6, IL-17F and IL-22 in PBMCs from Rheumatoid Arthritis Patients

Fig. (2) Cytokine levels from patients with rheumatoid arthritis treated with 100μM of Losartan and a Disease Activity Score for 28 joints (a IFN-γ; IL-2; IL-6; IL-17A; IL-17F; IL-22; TNF) and a Clinical Disease Activity Index (b IFN-γ; IL-2; IL-6; IL-17A; IL-17F; IL-22; TNF).